Actively Recruiting
Using Mobile Health Text Messaging to Improve Treatment Adherence for Sexually Transmitted Infections in Adolescents A Patient-Centered Randomized Trial to Reduce Health Disparities
Led by Children's National Research Institute · Updated on 2026-10-22
270
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a randomized clinical trial to study sexually transmitted infection STI treatment adherence among adolescents aged 15 to 21 years. The study compares patients who receive two-way text messaging reminders to those who receive usual care without text messages, aiming to evaluate whether text messaging can improve adherence by 20%. This patient-centered trial is sponsored by the Childrens National Research Institute and focuses on reducing health disparities in adolescent health outcomes. Participants are assigned to one of two groups one group receives text messages designed to support and remind them about their STI treatment, while the other group receives standard outpatient care without additional messaging. The intervention is behavioral and involves the use of mobile health technology to facilitate adherence to prescribed antibiotic treatments for gonorrhea, chlamydia, or pelvic inflammatory disease. During the study, participants adherence to their STI treatment will be measured within 1 to 21 days after filling their prescription. Researchers will also track whether the treatment was received within 1 to 21 days after diagnosis. Participants may expect participation to involve receiving text messages or usual care and completing follow-up assessments related to their treatment adherence. The total study duration extends until June 2027.
CONDITIONS
Brief Title
Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents
Research Team
M
Meleah Boyle, MPH
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here